A relevant question regarding the statin mechanism of action was whether its neuroprotective effect in stroke may be, at least partially, a result of not only downregulation of pro-apoptotic genes regulated by RelA-containing dimers but also of upregulation of anti-apoptotic genes regulated by c-Rel-containing dimers of NF-κB. The gene discussed is RELA; the disease is stroke disorder.